The cytotoxicty of 9,11-dehydroergosterol peroxide (DHEP) isolated from the fruiting bodies of Ganoderma lucidum on HeLa cells was studied. DHEP treatment for 48 h inhibited the proliferation of HeLa human cervical carcinoma cells with an IC 50 -value of 8.58 ± 0.98 μM. Morphological changes of DHEP-treated cells indicated that DHEP induced apoptosis in HeLa cells. To identify the cellular targets of DHEP, two-dimensional electrophoresis analysis was performed to compare the protein expression profiles of DHEP-treated cells with that of control cells. Proteins altered in expressional level after DHEP exposure were identified by MALDI-TOF MS/MS. The cytotoxic effect of DHEP was associated with regulated expression of 6 proteins. Stathmin 1 might be an important target-related protein of DHEP. The regulation of stathmin 1 by DHEP treatment was also confirmed by Western blotting.
Ganoderma lucidum, known as "Lingzhi" in China, has been used as a home remedy in traditional Chinese medicine (TCM). It has been used to treat or prevent a variety of diseases, including cancer. The antitumor activities of G. lucidum have been reported in both in vitro and in vivo studies [1a,1b] . The anti-cancer effects of G. lucidum were believed to be partly based on the cytotoxicity of triterpenes [2a-2d] . In our previous studies, we isolated triterpenes from G. lucidum [3a-3c] and studied the mechanism of their cytotoxic effects using a proteomic method [4a-4c] . In the present paper, 9,11-dehydroergosterol peroxide (DHEP) was isolated from the fruiting bodies of G. lucidum, and its cytotoxic effects on HeLa cells were investigated. Furthermore, the possible target-related proteins of DHEP were studied using a proteomic method.
Recently, Chen et al [5] reported the isolation of 9,11-dehydroergosterol peroxide from the fermentation mycelia of G. lucidum. In the present study, we have focused on the cytotoxic effects of DHEP on HeLa cells and the determination of possible target-related proteins of DHEP. As shown in Figure 1 , after treatment of the cells with increasing concentrations of DHEP for 24 h and 48 h, the cell survival rate of cells was reduced in a dose-and time-dependent manner. The IC 50 value of DHEP was 8.58 ± 0.98 μM after 48 h treatment. Treatment with 8 μM DHEP for 24 h induced typical morphological changes of apoptosis in HeLa cells. The effect of DHEP on the cell cycle of HeLa cells was also studied. DHEP did not cause considerable cell cycle arrest in HeLa cells (data not shown).
To investigate further the mechanism of cell toxicity induced by DHEP, protein profiles of control and DHEP-treated cells were studied by comparative proteomic analysis. Representative two-dimensional electrophoresis gel images for control and DHEPtreated cells are shown in A of Figure 2 . The gel images of the control and DHEP-treated groups were compared with PDQUEST software to identify the protein spot variations. After DHEP treatment, six protein spots with 1.5 fold or more increased or decreased intensity (p<0.05) were found, as shown in Figure 2 by arrows and by the expanded plots in 2B. In Table 1 , the average intensity values and the standard deviations of the spots and the fold differences between control and DHEP-treated group are shown. The fold change was represented by the ratio of the intensity value of the DHEP-treated group to the value of the control group. The results of MS/MS identification of the protein spots are shown in Table 2 , along with the protein score, coverage, and best ion score of each spot.
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The six target-related proteins found in the present study all play important roles in cell growth and cell functions. It is noteworthy that four of the six proteins found in the present study are either cytoskeletonregulating or cytoskeleton-related proteins. Stathmin 1, also known as p17, p18, p19, 19K, metablastin, oncoprotein 18, LAP 18 and Op18, is a microtubuledestabilizing phosphoprotein. Tropomyosin 4, keratin 17 and actin-like protein 8 are all cytoskeleton-related proteins. Among these four proteins, stathmin 1, as a cytoskeleton-regulating protein, might be the most important one. It was recently reported to be a novel therapeutic target for anti-cancer activity [6a] . Stathmin1 is highly expressed in a variety of human malignancies and has been found to play a crucial role in tumor cell proliferation and migration. Stathmin1 is critically involved in the construction and function of the mitotic spindle. By acting as a depolymerizer of microtubules and regulating the microtubule filament system, stathmin 1 could affect mitosis, as well as cell growth [6b]. Interestingly, both overexpression of stathmin 1 and inhibition of its expression can lead to apoptosis [6c]. In the present study, DHEP-treatment caused a decrease in stathmin 1 expression, which might be related to the apoptosis induced by DHEP. Ribonuclease H2 subunit C and proteasome 26S ATPase subunit 3 are also found to be possible targetrelated proteins of DHEP. Ribonuclease H2 subunit C is a non-catalytic subunit of ribonuclease H2, an endonuclease that specifically degrades the RNA of RNA:DNA hybrids. Ribonuclease H2 is essential for DNA integrity. Ribonuclease H2 subunit C might be involved in the interactions of ribonuclease H2 with other proteins [6d]. Proteasome 26S ATPase subunit 3 is one of the subunits of 26S proteasome that is involved in ATP-dependent degradation of ubiquitinated proteins [6e]. To confirm the change in expression level of stathmin 1 found in the proteomic study, the Western blotting assay was conducted. Consistent with the proteomic results, stathmin 1 was found to be down-regulated in DHEP-treated HeLa cells compared with control ( Figure 3 ).
In conclusion, DHEP isolated from G. lucidum was found to exhibit cytotoxic effects on HeLa cells, inhibit cell proliferation and induce apoptosis of HeLa cells. By using a proteomic method, stathmin 1, as well as tropomyosin 4, keratin 17, actin-like protein 8, ribonuclease H2 subunit C and proteasome 26S ATPase subunit 3 were found to be possible target-related proteins of DHEP. Our previous studies showed that the possible target-related proteins of Ganoderma triterpenes were 14-3-3 proteins, peroxiredoxins and others. Thus DHEP and Ganoderma triterpenes might exert their cytotoxicity through different mechanisms. 
Extraction and isolation:
The air-dried and powdered fruiting bodies of G. lucidum were extracted with 95% EtOH, as described previously [3a] . The crude extract (29 kg) was extracted with light petroleum (10 L×5) to give a brown oil (11.8 g), which was chromatographed on a silica gel column eluted successively with light petroleum -ethyl acetate (200:1-2:1 gradient system) to obtain 6 fractions (F1-F6). F6 was subjected to CC over Sephadex LH-20 (CHCl 3 -MeOH, 1:1), then purified by semi-preparative HPLC (MeOH-H 2 O, 90:10) to afford 9,11-dehydroergosterol peroxide (13 mg) [6f,6g].
Cell culture and cytotoxicity assay:
The HeLa human cervical carcinoma cell line (CCL-2) was obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA) and cultured in minimum essential medium complemented with 2 mM Lglutamine, 1.5 g/L sodium bicarbonate, 0.1 mM nonessential amino acids, 1.0 mM sodium pyruvate, 10% fetal bovine serum, 100 μg/mL streptomycin and 100 units/mL penicillin. The cytotoxity of DHEP was examined using a calorimetric tetrazolium (MTT) assay, as reported before [4a-4c] .
Imaging of morphological changes of DHEP-treated cells:
Nuclear staining was performed, as reported before [4a] , to detect morphological changes in the apoptotic process. Briefly, after treatment with DHEP (8 μM for 24 h), cells were washed with PBS, fixed with 4% paraformaldehyde (pH 7.4) for 30 min at room temperature and then stained with 5 mg/mL 4, 6-diamido-2-phenylindole hydrochloride (DAPI) for 10 min at room temperature. After PBS washes, cells were photographed using an Olympus UV light fluorescence microscope.
Two-dimensional protein electrophoresis analysis and MS/MS identification:
For preparing samples for electrophoresis analysis, 2 x 10 5 HeLa cells were cultured in 75 cm 2 flasks, and incubated for 48 h with either 8 µM DHEP or with 0.1% DMSO (solvent control). After incubation, cells were washed with icecold PBS and then scraped off with a cell scraper. After centrifugation at 3000 rpm for 10 min, the cell pellets were re-suspended in 200 µL lysis buffer (containing 7 M urea, 2 M thiourea, 2% CHAPS, 1% DTT, 0.8% Pharmalyte, and protease inhibitor) and kept on ice for 30 min. After centrifugation at 12,000 rpm for 30 min at 4°C, the supernatant containing the solubilized proteins was either used directly for two-dimensional protein electrophoresis analysis [4a-4c] or stored at -80°C. Paired samples (DHEP-treated and control) from 3 independent experiments were collected. The IEF protocol is as follows: rehydrated at 50 V for 12 h; 250 V with linear climb for 30 min; 1000 V with rapid climb for 60 min; 10,000 V with linear climb for 5 h; and 10,000 V with rapid climb until 60,000 V-h. Subsequently, the strips were equilibrated and then loaded onto 12% homogeneous SDS-PAGE gels for electrophoresis (PROTEIN II xi Multi-Cell system, Bio-Rad). After electrophoresis, the gels were silver-stained 1186 Natural Product Communications Vol. 5 (8) 2010 Cui et al.
using Bio-Rad Silver Stain Plus kit reagents (Bio-Rad), and scanned using a Densitometer GS-800 (Bio-Rad). For each protein sample, electrophoresis was conducted in triplicate. Image analysis was performed by comparing the 9 gels of the DHEP-treated group and the 9 gels of the control group with the PD-Quest software (Ver. 7.2, Bio-Rad). Protein spots with 1.5 fold (or more) increased or decreased intensity in DHEP-treated group compared with control (Student's t-test, p<0.05) were identified. Then, the protein spots were excised, digested, and finally identified by MALDI-TOF MS/MS as reported before [4a-4c] .
Western blotting: As reported before [4a-4c] , cells treated with either DHEP (8 µM for 48 h) or with 0.1% DMSO (solvent control) were collected and lysed in 10 volumes of cold lysis buffer (50 mM Tris-HCl, pH 7.2, 250 mM NaCl, 0.1% NP-40, 2 mM EDTA, 10% glycerol, 1 mM PMSF, 5 μg/mL Aprotinin, 5 μg/mlL Leupeptin) on ice for 30 min. After centrifugation, the supernatant containing protein was denatured by mixing with an equal volume of 2 × sample loading buffer and then boiling at 100 o C for 5 min. An aliquot (containing 50 μg protein) of the supernatant was used for Western blotting analysis. The primary antibodies used were rabbit anti-stathmin polyclonal antibody (1:200, Cell Signaling Technology, Danvers, MA 01923, USA) and rabbit anti-GAPDH polyclonal antibody (1:1000, Cell Signaling Technology). GAPDH, a house-keeping gene product, was used as internal control. The secondary antibody used was HRP-conjugated goat anti-rabbit IgG (1:1500, Sigma-Aldrich, St. Louis, MO 63103, USA). Blots were visualized using chemiluminescence (Pierce Biotechnology, Rockford, IL).
